Epilepsy Clinical Trial
Official title:
Feasibility of Mini-EEG in the Prehospital Setting
The EEG is widely used in the diagnosis of central nervous system pathology, including
epileptic seizures and epilepsy. Presently, EEG is available only during office hours in
most hospitals, pending on the availability of a clinical neurophysiologist and the lack of
oncall possibility outside these hours. Standard EEG devices are large and their operation
require meticulous application of several leads. The department of clinical neurophysiology
at Helsinki University Central Hospital has developed a mini-EEG device for use in the
emergency department as well as in the prehospital setting. The aims of this pilot study is
to evaluate the feasibility of the mini-EEG in the prehospital setting. Patients with a
decreased level of consciousness, as evaluated by the emergency medical provider on the
scene, are included. The mini--EEG device is to be used by a specially trained emergency
medical supervisor. EEG is otherwise obtained in a normal fashion, but only three electrodes
are used. The sample size is 30. Data are collected as a part of the clinical work in daily
practice. The aim is to collect observational data on feasibility, no clinical interventions
will be performed based on the EEG. No funding is needed as data is collected during daily
work.
The mini-EEG is a prototype EEG/EKG-adapter, designed by Helsinki Univeristy Central
Hospital, and as such, does not have a trade name. It is to be connected to a
monitor/defibrillator used by the EMS personel, currently the LifePak 15, manufactured by
Physio-Control, Redmond, WA 98052. (www.physio-control.com)
n/a
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04595513 -
Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants
|
Phase 1/Phase 2 | |
Completed |
NCT02909387 -
Adapting Project UPLIFT for Blacks in Georgia
|
N/A | |
Completed |
NCT05552924 -
Self Acupressure on Fatigue and Sleep Quality in Epilepsy Patients
|
N/A | |
Terminated |
NCT01668654 -
Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS
|
Phase 3 | |
Not yet recruiting |
NCT05068323 -
Impact of Interictal Epileptiform Activity on Some Cognitive Domains in Newly Diagnosed Epileptic Patients
|
N/A | |
Completed |
NCT03994718 -
Creative Arts II Study
|
N/A | |
Recruiting |
NCT04076449 -
Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
|
||
Completed |
NCT00782249 -
Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy
|
N/A | |
Completed |
NCT03683381 -
App-based Intervention for Treating Insomnia Among Patients With Epilepsy
|
N/A | |
Recruiting |
NCT05101161 -
Neurofeedback Using Implanted Deep Brain Stimulation Electrodes
|
N/A | |
Active, not recruiting |
NCT06034353 -
Impact of Pharmacist-led Cognitive Behavioral Intervention on Adherence and Quality of Life of Epileptic Patients
|
N/A | |
Recruiting |
NCT05769933 -
Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
|
||
Not yet recruiting |
NCT06408428 -
Glioma Intraoperative MicroElectroCorticoGraphy
|
N/A | |
Not yet recruiting |
NCT05559060 -
Comorbidities of Epilepsy(Cognitive and Psychiatric Dysfunction)
|
||
Completed |
NCT02977208 -
Impact of Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use
|
Phase 4 | |
Completed |
NCT02646631 -
Behavioral and Educational Tools to Improve Epilepsy Care
|
N/A | |
Completed |
NCT02952456 -
Phenomenological Approach of Epilepsy in Patients With Epilepsy
|
||
Recruiting |
NCT02539134 -
TAK-935 Multiple Rising Dose Study in Healthy Participants
|
Phase 1 | |
Terminated |
NCT02757547 -
Transcranial Magnetic Stimulation for Epilepsy
|
N/A | |
Completed |
NCT02491073 -
Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL)
|
N/A |